News

Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks to the ever-growing popularity of Eli Lilly's Zepbound and Novo Nordisk's Wegovy.
One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?
As GLP-1 adoption grows and new applications for the drugs come to light, experts say that could have sweeping impacts for ...
In a recent video spot, the 43-year-old athlete reveals that Ro helped her lose 31 pounds in eight months. “Yes, I’m on Ro.
Serena Williams is opening up about her fitness journey, revealing that she has lost 31 pounds using the injectable GLP-1 ...
The 23-time Grand Slam champion says the medication is no shortcut, but a tool alongside exercise, diet and discipline ...
Studies have linked GLP-1 medications to various eye conditions, some of which may lead to vision loss. Despite these ...
“Most users tolerate GLP-1 medications like Ozempic without serious oral health issues, but a subset experience notable side ...